Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neothetics NEOT

Healthcare Biotechnology
"Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients."

Recent & Breaking News (NDAQ:NEOT)

18 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  December 23, 2016

Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat

GlobeNewswire December 23, 2016

Neothetics Provides Business Update and Reports Third Quarter 2016 Financial Results

GlobeNewswire November 10, 2016

Neothetics to Provide a Business Update and Release Third Quarter 2016 Financial Results Thursday, November 10, 2016

GlobeNewswire November 3, 2016

Neothetics Provides Business Update and Reports Second Quarter 2016 Financial Results

GlobeNewswire August 11, 2016

Neothetics to Provide a Business Update and Release Second Quarter 2016 Financial Results Thursday, August 11, 2016

GlobeNewswire August 4, 2016

What Investors are Making of These Biotech Stocks? - ChemoCentryx, Alder Biopharma, Neothetics, and OvaScience

PR Newswire June 28, 2016

Neothetics Reports First Quarter 2016 Financial Results

GlobeNewswire May 12, 2016

Neothetics to Release First Quarter 2016 Financial Results

GlobeNewswire May 5, 2016

Stocks To Watch: Investors Are Considering These on Monday April 25th

Accesswire April 25, 2016

Trending Stocks To Have On Your Watch-list Friday (4/22/16)

Accesswire April 22, 2016

Neothetics to Present at the 15th Annual Needham Healthcare Conference

GlobeNewswire April 6, 2016

Neothetics Reports Fourth Quarter 2015 Financial Results

GlobeNewswire March 29, 2016

Neothetics Provides Update and Plan Forward for LIPO-202 Program

GlobeNewswire March 28, 2016

Neothetics Announces Leadership Change and Preliminary Update on LIPO-202

GlobeNewswire February 18, 2016

Where We Are Headed - Free Research on Ultra Clean Holdings, Career Education, Citizens and Neothetics

Accesswire December 18, 2015

Neothetics Reports LIPO-202 Top-Line Phase 3 Trial Results for the Reduction of Central Abdominal Bulging

GlobeNewswire December 14, 2015

Neothetics Announces Issuance by USPTO of Fourth Patent Directed to LIPO-202 Lead Clinical Asset

GlobeNewswire December 7, 2015

Technical Insight on Equity Market - Research on Neothetics, Travelzoo, eGain and Minerva Neurosciences

Accesswire December 1, 2015

Neothetics Tightens Guidance for Timing of Top-Line Pivotal Phase 3 Data

GlobeNewswire December 1, 2015